Professor Michael Baumann is director of the German Cancer Research Center (DKFZ) in Heidelberg, Europe’s largest cancer research institute. He has become internationally recognised within the field of experimental radiotherapy and has played a vital role in the development of individualised radiotherapy, which adapts cancer treatment to the individual patient.
Michael Baumann has enjoyed a close connection to Aarhus University since the 1980s, and he was a prominent member of the international panel that advised the Danish Health Authority to set up the Danish Centre for Particle Therapy (DCPT) in Aarhus in 2012. The DCPT was central to Denmark becoming a world leader in radiation oncology research, and, since 2017, Michael Baumann has been a member of the centre’s Scientific Advisory Board.
Under Michael Baumann’s leadership, the DCPT collaborates closely with leading clinical institutions for cancer research, including the newly established Danish Comprehensive Cancer Center (DCCC), where Aarhus University and Aarhus University Hospital play an important role.